Literature DB >> 27293119

Venous hypertensive myelopathy associated with cervical spondylosis.

Seiji Okada1, Charles Chang2, Geraldine Chang3, James J Yue4.   

Abstract

BACKGROUND CONTEXT: Venous hypertensive myelopathy (VHM) results from spinal vascular malformations of arteriovenous shunting that increases spinal venous pressure, leading to congestive edema and neurologic dysfunction. There has been no report of VHM associated with cervical spondylotic myelopathy (CSM).
PURPOSE: The aim of this study was to report an extremely rare case of VHM likely due to CSM. STUDY
DESIGN: This study is a case report and review of the literature. PATIENT SAMPLE: The patient was a 51-year-old man with CSM exhibiting relatively rapid neurologic deterioration with an abnormal expansion of a centromedullary hyperintense lesion on T2-weighted magnetic resonance imaging (MRI) in the absence of traumatic injury.
METHODS: Neurologic examination and radiologic imaging were taken by various means.
RESULTS: The patient developed a cervical radiculopathy, followed by gait disturbance and motor weakness. The MRI of the cervical spine demonstrated spinal canal stenosis due to disc bulging and flavum hypertrophy at the C5/C6 and C6/C7 levels as well as hyperintense area over the C5-C7 levels on T2-weighted images. Although decompression surgery was planned, an acute inflammatory process such as transverse myelitis or demyelinating disease other than cord compression was also considered, and the patient received intravenous steroids. His walking improved for several days. However, his symptoms then became significantly worse, and he had difficulty walking. Subsequent MRI demonstrated marked progression of the T2 hyperintense lesion over the C4-T1 vertebral levels. Flow voids were also noted on the dorsal surface of the upper cervical cord on T2-weighted MRI. His lab work, medical history, and the local enhancement on contrast-enhanced MRI indicated low probability of spinal inflammatory diseases. Therefore, the decision was made to perform anterior cervical discectomy and fusion surgery on two levels. Following surgery, his symptoms improved promptly.
CONCLUSIONS: Our case indicates that VHM could be caused by spondylotic cord compression in the absence of spinal vascular malformations. The diagnostic features for VHM are progressive deterioration of myelopathy, easing/worsening of symptoms associated with postural changes, and centromedullary hyperintensity over multiple segments and the flow voids on dorsal surface of the spinal cord on T2-weighted MRI.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ascending myelopathy; Diagnosis; Magnetic resonance image; Spinal inflammatory diseases; Spondylosis; Venous hypertensive myelopathy

Mesh:

Year:  2016        PMID: 27293119     DOI: 10.1016/j.spinee.2016.06.003

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  4 in total

1.  Potential biomarkers of spinal dural arteriovenous fistula: C4BPA and C1QA.

Authors:  Yinqing Wang; Yongjie Ma; Chengbin Yang; Hongqi Zhang; Xiahe Huang; Kun Yang; Fei Lan; Jingxuan Fu; Zihao Song; An Tian; Yueshan Feng; Tianqi Tu; Haifeng Li; Tao Hong; Yingchun Wang
Journal:  J Neuroinflammation       Date:  2022-06-22       Impact factor: 9.587

Review 2.  Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies.

Authors:  Stefan Weidauer; Marlies Wagner; Michael Nichtweiß
Journal:  Clin Neuroradiol       Date:  2017-06-30       Impact factor: 3.156

3.  Spinal cord swelling in patients with cervical compression myelopathy.

Authors:  Naohiro Tachibana; Takeshi Oichi; So Kato; Yusuke Sato; Hiroyuki Hasebe; Shima Hirai; Yuki Taniguchi; Yoshitaka Matsubayashi; Harushi Mori; Sakae Tanaka; Yasushi Oshima
Journal:  BMC Musculoskelet Disord       Date:  2019-06-14       Impact factor: 2.362

4.  Clinical control study of traditional Chinese medicine hot compress combined with traction in the treatment of cervical spondylotic radiculopathy: Study protocol.

Authors:  Xing Ding; Jinze Wu; Qixing Shen; Jinhai Xu; Wen Mo
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.